 Treatment psoriasis piritrexim lipid-soluble folate antagonist Methotrexate effective convenient treatment severe psoriasis use development hepatic fibrosis cirrhosis small number patients mechanism hepatotoxicity unknown result intracellular polyglutamation prolonged retention methotrexate cell Piritrexim isethionate lipid-soluble antifolate mechanism action similar methotrexate piritrexim effective treatment psoriasis long-term hepatotoxicity phase I/II clinical trial severe chronic plaque psoriasis safety efficacy oral piritrexim therapy experience oncologic trials patient twice-daily dosage consecutive days weeks Dosages mg day Improvement lesion scores percentage body involvement significant dose mg twice Fifteen patients weeks therapy improvement lesion scores Improvement recrudescence lesions rest period Adverse experiences minimal dose Piritrexim efficacious treatment psoriasis